Biossil Labs Inc. Acquires SYN-004 and Related Assets from Theriva Biologics, Inc.
Acquiring Company
Biossil Labs
Acquired Company
Theriva Biologics
Canada
RockvilleBiotechnologyHealth CareBiotechnologyHealth CareScience And EngineeringTherapeuticsBiopharmaDescription
Theriva Biologics, Inc. has entered into an Asset Purchase Agreement with Biossil Labs Inc. to sell its assets related to the SYN-004 oral β-lactamase product candidate. The transaction included an upfront payment along with potential future milestone payments. The closing occurred simultaneously with the signing of the agreement on October 30, 2026.
Who to call at Biossil Labs, and when
When Biossil Labs changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Biossil Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biossil Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biossil Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biossil Labs makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Theriva Biologics?
Theriva Biologics was acquired by Biossil Labs, based in Canada. The deal was reported on November 2, 2026. Biossil Labs Inc. is a Canadian corporation engaged in the research and development of lab-based solutions. They focus on innovative health products and are committed to enhancing therapeutic outcomes. Biossil Labs is privately held and operates in Biotechnology.
When did Biossil Labs acquire Theriva Biologics?
Biossil Labs's acquisition of Theriva Biologics was reported on November 2, 2026. Theriva Biologics, Inc. has entered into an Asset Purchase Agreement with Biossil Labs Inc. to sell its assets related to the SYN-004 oral β-lactamase product candidate. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Theriva Biologics do?
Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc. Theriva™ is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. It is publicly traded (TOVX), operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.